Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) is designed to support genomic programs managed by the Center for Cancer Genomics (CCG). The overall goal of all CCG programs is to help elucidate the mechanisms of cancer initiation and evolution, as well as resistance to therapy by means of genomic characterization of well-annotated, high quality tumor samples. These data could, in the future, be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. It is not the intent of this FOA to fund follow-up translational and functional studies, but rather to enable the cancer research community to develop a new generation of studies that will leverage the genomic findings from NCI programs for the benefit of cancer patients. NCI project data, both ongoing and completed, will provide a unique reference resource on cancer-specific genomic aberrations for the cancer research community at large.


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): November 12, 2020

RFA-CA-20-053 Expiration Date November 13, 2020

Agency Website



Amount Description

Application budgets are limited to $300,000/year in direct costs, but need to reflect the actual needs of the proposed project.

The maximum project period is 5 years

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 12, 2020